Iron metabolism and drug resistance in cancer

被引:90
作者
Kazan, Hasan Huseyin [1 ]
Urfali-Mamatoglu, Cagri [1 ]
Gunduz, Ufuk [1 ]
机构
[1] Middle East Tech Univ, Dept Biol, Univ Mah Dumlupinar Blv 1, TR-06800 Ankara, Turkey
关键词
Iron metabolism; Chemotherapy; Drug resistance; Ferroptosis; DOXORUBICIN-TRANSFERRIN CONJUGATE; AGENT GALLIUM NITRATE; HUMAN-LEUKEMIC-CELLS; MULTIDRUG-RESISTANCE; BREAST-CANCER; CHEMOTHERAPEUTIC-AGENTS; RECEPTOR EXPRESSION; MULTIPLE-MYELOMA; CARCINOMA CELLS; P-GLYCOPROTEIN;
D O I
10.1007/s10534-017-0037-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Iron is an essential inorganic element for various cellular events. It is directly associated with cell proliferation and growth; therefore, it is expected that iron metabolism is altered in tumor cells which usually have rapid growth rates. The studies on iron metabolism of tumor cells have shown that tumor cells necessitated higher concentrations of iron and the genes of iron uptake proteins were highly over-expressed. However, there are limited number of studies on overall iron metabolism in drug-resistant tumor cells. In this article, we evaluated the studies reporting the relationship between drug resistance and iron metabolism and the utilization of this knowledge for the reversal of drug resistance. Also, the studies on iron-related cell death mechanism, ferroptosis, and its relation to drug resistance were reviewed. We focus on the importance of iron metabolism in drug-resistant cancer cells and how alterations in iron metabolism participate in drug-resistant phenotype.
引用
收藏
页码:629 / 641
页数:13
相关论文
共 95 条
[81]   Metallothionein-1G Facilitates Sorafenib Resistance Through Inhibition of Ferroptosis [J].
Sun, Xiaofang ;
Niu, Xiaohua ;
Chen, Ruochan ;
He, Wenyin ;
Chen, De ;
Kang, Rui ;
Tang, Daolin .
HEPATOLOGY, 2016, 64 (02) :488-500
[82]   Modulation of doxorubicin resistance in a doxorubicin-resistant human leukaemia cell by an immunoliposome targeting transferring receptor [J].
Suzuki, S ;
Inoue, K ;
Hongoh, A ;
Hashimoto, Y ;
Yamazoe, Y .
BRITISH JOURNAL OF CANCER, 1997, 76 (01) :83-89
[83]   Studies on the Intestinal Absorption Characteristics of Sulfasalazine, a Breast Cancer Resistance Protein (BCRP) Substrate [J].
Tomaru, Atsuko ;
Morimoto, Nozomi ;
Morishita, Mariko ;
Takayama, Kozo ;
Fujita, Takuya ;
Maeda, Kazuya ;
Kusuhara, Hiroyuki ;
Sugiyama, Yuichi .
DRUG METABOLISM AND PHARMACOKINETICS, 2013, 28 (01) :71-74
[84]  
Torti Suzy V., 2013, Critical Reviews in Oncogenesis, V18, P435
[85]   Iron and cancer: more ore to be mined [J].
Torti, Suzy V. ;
Torti, Frank M. .
NATURE REVIEWS CANCER, 2013, 13 (05) :342-355
[86]   Ironing Out Cancer [J].
Torti, Suzy V. ;
Torti, Frank M. .
CANCER RESEARCH, 2011, 71 (05) :1511-1514
[87]   The ferritin superfamily: Supramolecular templates for materials synthesis [J].
Uchida, Masaki ;
Kang, Sebyung ;
Reichhardt, Courtney ;
Harlen, Kevin ;
Douglas, Trevor .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2010, 1800 (08) :834-845
[88]   Development of sulfasalazine resistance in human T cells induces expression of the multidrug resistance transporter ABCG2 (BCRP) and augmented production of TNFα [J].
van der Heijden, J ;
de Jong, MC ;
Dijkmans, BAC ;
Lems, WF ;
Oerlemans, R ;
Kathmann, I ;
Schalkwijk, CG ;
Scheffer, GL ;
Scheper, RJ ;
Jansen, G .
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (02) :138-143
[89]   Nitrogen monoxide (NO)-mediated iron release from cells is linked to NO-induced glutathione efflux via multildrug resistance-associated protein 1 [J].
Watts, Ralph N. ;
Hawkins, Clare ;
Ponka, Prem ;
Richardson, Des R. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (20) :7670-7675
[90]   A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics [J].
Whitnall, Megan ;
Howard, Jonathan ;
Ponka, Prem ;
Richardson, Des R. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (40) :14901-14906